Stockreport

UroGen Pharma (URGN) CEO Ron Bentsur on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF UroGen Pharma (NASDAQ: URGN ) Q3 2018 Earnings Call November 12, 2018 8:30 AM ET Executives Kate Bechtold - Director of Corporate Communications and IR Ron [Read more]